NCT05604209
- Conditions
- HIV Vaccine, HIV-1-infection
- Locations
-
- University of North Carolina Chapel Hill, North Carolina, United States
- Duke University Durham, North Carolina, United States
Clinical trial condition
Explore clinical trials studying HIV Vaccine. Study availability and eligibility vary by location and protocol.
NCT05604209
NCT06700447